We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

25 hedge funds and large institutions have $61.7M invested in Cipher Pharmaceuticals Inc. in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $55.7M → $61.7M (+$6.06M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

19% less funds holding

Funds holding: 3125 (-6)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
10
Reduced
11
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
-$980K -108,141 Closed
SIM
27
Spark Investment Management
New York
-$569K -63,000 Closed
QI
28
QS Investors
New York
-$513K -44,700 Closed
Two Sigma Advisers
29
Two Sigma Advisers
New York
-$127K -14,000 Closed
RFC
30
Russell Frank Company
Washington
-$92K -10,191 Closed
PCM
31
Prelude Capital Management
New York
-$34K -3,700 Closed
Citigroup
32
Citigroup
New York
-$18K -1,933 Closed

CPHR Hedge Fund Activity: Q2 2015 in Review

25 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q2 2015, worth a combined $61.7M — up 11% from $55.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CPHR and 1 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 10 added.

The largest buyer was Grandeur Peak Global Advisors, adding an estimated $11M. The largest seller was Taylor Asset Management, cutting an estimated $1.51M.

  • 25 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q2 2015, down from 31 in Q1 2015.
  • Funds reported $61.7M of Cipher Pharmaceuticals Inc. stock for Q2 2015, up 11% quarter-over-quarter.
  • 1 fund opened new Cipher Pharmaceuticals Inc. positions in Q2 2015 and 7 closed out, a net change of -6 holders.
  • The largest Cipher Pharmaceuticals Inc. buyer in Q2 2015 was Grandeur Peak Global Advisors, an estimated $11M added.
  • The largest Cipher Pharmaceuticals Inc. seller in Q2 2015 was Taylor Asset Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q2 2015.